NCT00722527Recruiting
Molecular Biology of Polycythemia and Thrombocytosis
Source: ClinicalTrials.gov · Last updated 9 Mar 2026
Brief summary (registry, in English)
Our study is designed to characterize the clinical picture and genetic pattern of Polycythemia and Thrombocytosis. The purpose of this project is to find a gene and its mutation that causes these disorders. When this is accomplished, new therapies to control and eventually cure the disorder can be designed.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 23 Jul 2008
- Start date
- Jul 2006
- Primary completion date
- Jul 2028
- Lead sponsor
- University of Utah
- NCT number
- NCT00722527
What you commit to
- Study type: Observational
- Planned participants: 200
- From Jul 2006 to the primary completion date, Jul 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Subjects with heart disease, left to right heart shunt or severe pulmonary disease
Other
- Subjects who have a known acquired cause of polycythemia and thrombocytosis
Who the study is looking for
- Subjects with an elevated hemoglobin concentration (\>18 in males and \>16 in females)
- Subjects with an elevated platelet count (\>450,000)
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Utah Coordinator of this site? Confirm its status | Salt Lake City | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.